Douglas Grossman

8.8k total citations · 1 hit paper
146 papers, 6.0k citations indexed

About

Douglas Grossman is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Douglas Grossman has authored 146 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Oncology, 48 papers in Molecular Biology and 46 papers in Dermatology. Recurrent topics in Douglas Grossman's work include Cutaneous Melanoma Detection and Management (61 papers), Skin Protection and Aging (31 papers) and Cell death mechanisms and regulation (18 papers). Douglas Grossman is often cited by papers focused on Cutaneous Melanoma Detection and Management (61 papers), Skin Protection and Aging (31 papers) and Cell death mechanisms and regulation (18 papers). Douglas Grossman collaborates with scholars based in United States, Canada and United Kingdom. Douglas Grossman's co-authors include Dario C. Altieri, Fengzhi Li, Tong Liu, Jennifer M. McNiff, Agnessa Gadeliya Goodson, Sancy A. Leachman, Scott R. Florell, Douglas E. Brash, Paul Kim and Simona Tognin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Douglas Grossman

140 papers receiving 5.8k citations

Hit Papers

Regulation of apoptosis at cell division by p34 cdc2 phos... 2000 2026 2008 2017 2000 100 200 300 400 500

Peers

Douglas Grossman
Hensin Tsao United States
Ellen L. Berg United States
Paul Nathan United Kingdom
Qun Lin China
Douglas Grossman
Citations per year, relative to Douglas Grossman Douglas Grossman (= 1×) peers Shigetoshi Sano

Countries citing papers authored by Douglas Grossman

Since Specialization
Citations

This map shows the geographic impact of Douglas Grossman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Grossman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Grossman more than expected).

Fields of papers citing papers by Douglas Grossman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Grossman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Grossman. The network helps show where Douglas Grossman may publish in the future.

Co-authorship network of co-authors of Douglas Grossman

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Grossman. A scholar is included among the top collaborators of Douglas Grossman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Grossman. Douglas Grossman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yelena P., Tammy K. Stump, Heather Smith, et al.. (2024). Challenges and lessons learned in recruiting participants for school-based disease prevention programs during COVID-19. Contemporary Clinical Trials Communications. 42. 101399–101399. 1 indexed citations
2.
Horns, Joshua J., et al.. (2024). The benefit of sentinel lymph node biopsy in elderly patients with melanoma. The American Journal of Surgery. 237. 115896–115896. 2 indexed citations
3.
Florell, Scott R., Chris Stubben, Kenneth M. Boucher, et al.. (2024). MicroRNA Signatures Associated with Basal Cell Carcinoma Subtypes. SHILAP Revista de lepidopterología. 4(4). 100286–100286. 1 indexed citations
4.
Wu, Yelena P., Tammy K. Stump, Jennifer L. Hay, et al.. (2023). The Family Lifestyles, Actions and Risk Education (FLARE) study: Protocol for a randomized controlled trial of a sun protection intervention for children of melanoma survivors. Contemporary Clinical Trials. 131. 107276–107276. 1 indexed citations
5.
Boucher, Kenneth M., et al.. (2023). Electrical Impedance Dermography Differentiates Squamous Cell Carcinoma In Situ from Inflamed Seborrheic Keratoses. SHILAP Revista de lepidopterología. 3(3). 100194–100194. 2 indexed citations
6.
Stump, Tammy K., Yeonjung Jo, Jonathan Chipman, et al.. (2023). Objectively-Assessed Ultraviolet Radiation Exposure and Sunburn Occurrence. International Journal of Environmental Research and Public Health. 20(7). 5234–5234. 3 indexed citations
7.
Jensen, Jakob D., Manusheela Pokharel, Helen M. Lillie, et al.. (2022). Developing skin cancer education materials for darker skin populations: crowdsourced design, message targeting, and acral lentiginous melanoma. Journal of Behavioral Medicine. 46(3). 377–390. 1 indexed citations
8.
Liu, Tong, et al.. (2021). A Randomized Double-blind Placebo-controlled Trial of Oral Aspirin for Protection of Melanocytic Nevi Against UV-induced DNA Damage. Cancer Prevention Research. 15(2). 129–138. 1 indexed citations
9.
Chang, Michael S., Sancy A. Leachman, Elizabeth Berry, et al.. (2021). Changes in melanoma care practices during the COVID-19 pandemic: a multi-institutional cross-sectional survey. Dermatology Online Journal. 27(4). 7 indexed citations
10.
Grossman, Douglas, et al.. (2020). Vitamin D, melanoma risk, and tumor thickness in PLCO cancer screening trial patients. JAAPA. 33(6). 35–41. 2 indexed citations
11.
Wu, Yelena P., Kenneth M. Boucher, Nan Hu, et al.. (2019). A pilot study of a telehealth family‐focused melanoma preventive intervention for children with a family history of melanoma. Psycho-Oncology. 29(1). 148–155. 4 indexed citations
12.
Kumar, Dileep, Ethika Tyagi, Tong Liu, et al.. (2018). Aspirin Suppresses PGE2 and Activates AMP Kinase to Inhibit Melanoma Cell Motility, Pigmentation, and Selective Tumor Growth In Vivo. Cancer Prevention Research. 11(10). 629–642. 40 indexed citations
13.
Cassidy, Pamela B., Tong Liu, Scott R. Florell, et al.. (2016). A Phase II Randomized Placebo-Controlled Trial of Oral N -acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress In Vivo. Cancer Prevention Research. 10(1). 36–44. 20 indexed citations
14.
McKenzie, Jodi A., Tong Liu, Sun-Young Jung, et al.. (2013). Survivin promotion of melanoma metastasis requires upregulation of α 5 integrin. Carcinogenesis. 34(9). 2137–2144. 35 indexed citations
15.
McKenzie, Jodi A., et al.. (2010). Survivin Enhances Motility of Melanoma Cells by Supporting Akt Activation and α5 Integrin Upregulation. Cancer Research. 70(20). 7927–7937. 72 indexed citations
16.
Goodson, Agnessa Gadeliya, Murray A. Cotter, Pamela B. Cassidy, et al.. (2009). Use of Oral N -Acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress: Towards a Novel Paradigm for Melanoma Chemoprevention. Clinical Cancer Research. 15(23). 7434–7440. 34 indexed citations
17.
Thomas, Joshua, Tong Liu, Murray A. Cotter, et al.. (2007). Melanocyte Expression of Survivin Promotes Development and Metastasis of UV-Induced Melanoma in HGF-Transgenic Mice. Cancer Research. 67(11). 5172–5178. 39 indexed citations
18.
Bowen, Glen M., et al.. (2007). Digital Dermoscopic Monitoring of Atypical Nevi in Patients at Risk for Melanoma. Dermatologic Surgery. 33(10). 1198–1205. 9 indexed citations
19.
Grossman, Douglas & David J. Leffell. (1997). The molecular basis of nonmelanoma skin cancer: new understanding.. PubMed. 133(10). 1263–70. 131 indexed citations
20.
Mollick, J A, G G Miller, James M. Musser, et al.. (1993). A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C.. Journal of Clinical Investigation. 92(2). 710–719. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026